Clinical Trial Update: Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating TYK-01054 capsules in patients with advanced solid tumors, including malignant mesothelioma; the study is currently NOT_YE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Solid Tumors

Drugs mentioned

• TYK-01054 capsules (TYK-01054)

Snippet

Sponsor: TYK Medicines, Inc | Conditions: Solid Tumor Malignancies, Malignant Mesothelioma (MM) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING